PROTECTED-UK – Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level

Rudall, Nicola; McKenzie, Catherine; Landa, J; Bourne, Richard S; Bates, Ian; Shulman, Rob

doi:10.1111/ijpp.12304

Cited by 26 publications

(32 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is the first study that sought to examine the clinical impact of the effects of a combination of important resources to reduce medication errors in critical care patients. Previously, we have evaluated the association between pharmacist‐led medication intervention activity and individual resources in an unstructured manner . Consensus was achieved from a relatively small but expert group of UK critical care pharmacists that lead on the development of UK critical care pharmacy practice .…”

Section: Discussionmentioning

confidence: 99%

“…In a previous multicentre study of UK critical care pharmacist's medicines‐related interventions (PROTECTED UK), we reported the important clinical impact pharmacists had in reducing medication errors and improving medicines optimisation . However, there was variation in the medicines‐related outcomes that went beyond the demographics of the individual practitioner and are more likely to be explained by the wider unit‐level utilisation of evidence‐based medication error reduction interventions or resources …”

Section: Introductionmentioning

confidence: 96%

See 1 more Smart Citation

Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation

Bourne

Shulman

Jennings

2018

International Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 96%

Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation

Bourne

Shulman

Jennings

2018

International Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

show abstract

“…wąski indeks terapeutyczny, nieswoistość, duży potencjał indukcji oporności, które wpływają na znaczną toksyczność leczenia czy ograniczenie możliwości ordynowania leków w monoterapii. Implikuje to konieczność wprowadzania procedur wielolekowych [19,32,39]. Sytuację dodatkowo komplikują substancje przyjmowane w terapiach wspomagających, łagodzące skutki uboczne chemioterapii, leki przeciwbólowe, terapie chorób współistniejących oraz leki, które pacjent przyjmuje w ramach samoleczenia.…”

Section: Interakcje Lekowe W Trakcie Leczenia Przeciwnowotworowegounclassified

“…Brak uregulowań prawnych, które określałyby liczbę zatrudnionych farmaceutów w stosunku do liczby łóżek szpitalnych. W krajach zachodnich opieka farmaceutyczna funkcjonuje przynosząc korzyści finansowe, jak i społeczne [39]. Mimo to, w Polsce temat opieki farmaceutycznej pozostaje głównie w sferze kształcenia studentów…”

unclassified

Pharmaceutical care of patients with cancer

Bryła¹,

Burkacka²,

Budnik-Szymoniuk³

et al. 2019

Farm Pol.

View full text Add to dashboard Cite

Pharmaceutical care of patients with cancer • A comprehensive approach to the needs of an oncological patient requires the involvement of specialists of various fields. Regardless of the type of therapy or medical problem effective communication, the transmission of informations, the subjective treatment of the patient (as a member of therapy) is important. This procedure is called "adherence". Understanding the legitimacy of diagnostic activities, assumptions and course of treatment by the patient is the way to its acceptance and increase of effectiveness of therapy. Cooperation between medical staff and the patient and their caregivers should be continuous and dynamic, adepted to changing needs (depending on the stage of treatment, type and severity of the disease).

show abstract

“…Our opinion is in agreement with Rudal et al, who collected intervention data from 21 adult critical care units over 14 days and concluded that a clinical pharmacist is essential for safe and optimised patient medication therapy and that an extended and developed pharmacy service is expected to reduce errors. Moreover, they recommended that clinical pharmacy services should be adequately staffed to enable adequate time for prescription review and maximal therapy optimization 51 .…”

Section: Effect Of Mean Number Of Medication Errors Onmentioning

confidence: 99%

Untitled

2018

IJPSR

View full text Add to dashboard Cite

Background: The limited evidence of the critical role of clinical pharmacists in Egyptian teaching hospitals led to the fact that critical care pharmacists' responsibilities are still focused on dispensing and drug distribution. Objective: Assess the important role of clinical pharmacy service activities in an Egyptian intensive care unit (ICU) by describing the impact of medication errors on clinical outcome of critically ill-patients with renal insufficiency. Methods: An observational retrospective cohort study was carried out over a five months period on patients admitted to ICU with estimated creatinine clearance (CrCl) less than 50 ml/min on admission and known to have chronic kidney disease (CKD). Patient records, physician orders, pharmacy and nursing notes of 69 patients were collected and reviewed by a clinical pharmacist. Medication errors were assessed. Main outcome measure was Length of ICU stay and mortality. Results: One hundred and seventeen MEs were identified; prescribing errors (58.9%), wrong administration technique (17.9%), drug-preparation errors (11.9%) and monitoring errors (11.1%). Errors in renal dose adjustment were the most frequent prescribing errors (66.7%). The length of ICU stay was positively correlated with number of medication errors per prescription (r=0.392, p=0.001) and mortality was associated with significantly higher number of medication errors (p=0.01). Only 29% of errors observed were documented in pharmacy records and 93% of documented pharmacy interventions were accepted by the physicians. Conclusion: Decreasing morbidity and mortality in critically ill Egyptian patients with renal insufficiency may be achieved through optimizing clinical pharmacy services with prescription intervention activities.

show abstract

PROTECTED-UK – Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level

Abstract: A CP is essential for safe and optimised patient medication therapy; an extended and developed pharmacy service is expected to reduce errors. CP services should be adequately staffed to enable adequate time for prescription review and maximal therapy optimisation.

Cited by 26 publications

References 24 publications

Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation

Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation

Pharmaceutical care of patients with cancer

Untitled

Contact Info

Product

Resources

About